{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:19:59Z","timestamp":1786994399904,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.mrgentox.2006.02.004","type":"journal-article","created":{"date-parts":[[2006,7,8]],"date-time":"2006-07-08T07:20:12Z","timestamp":1152343212000},"page":"153-159","source":"Crossref","is-referenced-by-count":28,"title":["Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test"],"prefix":"10.1016","volume":"607","author":[{"given":"Willi","family":"Suter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joerg","family":"Martus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Elhajouji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrgentox.2006.02.004_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0193-953X(18)30265-X","article-title":"The stimulants","volume":"15","author":"Wilens","year":"1992","journal-title":"Psychiatry Clin. North. Am."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1469-7610.1977.tb00425.x","article-title":"A review of stimulant drug research with hyperactive children","volume":"18","author":"Barkley","year":"1977","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib3","doi-asserted-by":"crossref","unstructured":"K. Kavale. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis, J. Learn. Disabil. 15, 280-289.","DOI":"10.1177\/002221948201500508"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0193-953X(18)30255-7","article-title":"Pharmacologic treatment of attention deficit hyperactivity disorder","volume":"15","author":"Greenhill","year":"1992","journal-title":"Psychiatr. Clin. North. Am."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1383-5718(03)00053-6","article-title":"d-Methylphenidate is non-genotoxic in in vitro and in vivo assays","volume":"537","author":"Teo","year":"2003","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib6","unstructured":"ICH Harmonised Tripartite Guideline (S2A), Guidance on specific aspects of regulatory genotoxicity tests (1995)."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib7","unstructured":"ICH Harmonised Tripartite Guideline (S2B), Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals (1997)."},{"issue":"Suppl. 7","key":"10.1016\/j.mrgentox.2006.02.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.2860080802","article-title":"Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals","volume":"8","author":"Mortelmans","year":"1986","journal-title":"Environ. Mol. Mutagenesis"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib9","first-page":"419","article-title":"L5178Y mouse lymphoma mutagenesis assay of coded chemicals incorporating analyses of the colony size distribution","volume":"5","author":"Rudd","year":"1983","journal-title":"Environ. Mol. Mutagenesis"},{"issue":"Suppl. 10","key":"10.1016\/j.mrgentox.2006.02.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/em.2850100502","article-title":"Chromosomal aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals","volume":"10","author":"Galloway","year":"1987","journal-title":"Environ. Mol. Mutagenesis"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib11","first-page":"110A","article-title":"Commonly used pediatric drugs, sister chromatid exchanges and the cell cycle","volume":"29","author":"Walker","year":"1977","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.mrgentox.2006.02.004_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2005.01.003","article-title":"Cytogenetic effects in children treated with methylphenidate","volume":"230","author":"El-Zein","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib13","unstructured":"OECD In vitro Mammalian Chromosome Aberration Test, OECD guidelines for the testing of chemicals 473, 21 July 1997."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib14","series-title":"Mutagenicity Testing: A Practical Approach","first-page":"187","article-title":"Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells","author":"Dean","year":"1985"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jmg.13.2.103","article-title":"Annotation: classification and relationships of induced chromosomal structural changes","volume":"13","author":"Savage","year":"1976","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib16","unstructured":"D. Scott, N.D. Danford, B.J. Dean, D. Kirkland, C.R. Richardson,, In vitro chromosome aberration assays, in: B.J., Dean (Ed.), Report of the Sub-Committee on Guidelines for Mutagenicity Testing, Swansea, United Kingdom Environmental Mutagen Society, 1983, pp. 41\u201364."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0165-1218(87)90016-4","article-title":"Guidelines for the conduct of micronucleus assays in mammalian bone marrow erythrocytes","volume":"189","author":"Mac Gregor","year":"1987","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib18","unstructured":"OECD Mammalian Erythrocyte Micronucleus Test, OECD guidelines for the testing of chemicals 474, 21 July 1997."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/em.2860080611","article-title":"Genotoxic effects in cultured mammalian cells produced by low pH treatment conditions and increased ion concentrations","volume":"8","author":"Brusick","year":"1986","journal-title":"Environ. Mol. Mutagen."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/mutage\/7.2.95","article-title":"Chromosomal aberration tests in vitro: problems with protocol design and interpretation of results","volume":"7","author":"Kirkland","year":"1992","journal-title":"Mutagenesis"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2005.02.004","article-title":"Evaluation of the ability of a battery of three in vitro genotoxicity test to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predicitivity","volume":"584","author":"Kirkland","year":"2005","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib22","unstructured":"National Toxicology Program, Technical Report Series. Toxicology and carcinogenesis studies of methylphenidate hydrochloride (CAS No. 298-59-9) in F344\/N rats and B6C3F1 mice. No. 439 (1995) 1-294."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib23","first-page":"708","article-title":"A study of methylphenidate in man with respect to its major metabolite","volume":"10","author":"Redalieu","year":"1982","journal-title":"Drug Metabolism Disposition"},{"key":"10.1016\/j.mrgentox.2006.02.004_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003088-200342040-00007","article-title":"Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults","volume":"42","author":"Markowitz","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib25","first-page":"535","article-title":"Metabolism and disposition of methylphenidate 14C studies in man and animals","volume":"191","author":"Faraj","year":"1974","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1023\/A:1018956526016","article-title":"Enantioselective pharmacokinetics of dl-threo methylphenidate in humans","volume":"10","author":"Srinivas","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1021\/jm00142a021","article-title":"Synthesis and pharmacology of hydroxylated metabolites of methylphenidate","volume":"24","author":"Patrick","year":"1981","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.mrgentox.2006.02.004_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canlet.2005.05.038","article-title":"Comments on \u2018Cytogenetic effects in children treated with methylphenidate\u2019 by El-Zein et al","volume":"230","author":"Preston","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0165-7992(88)90035-8","article-title":"Mutagenicity studies on paracetamol in human volunteers. I. Cytogenetic analysis of peripheral lymphocytes and lipid peroxidation in plasma","volume":"209","author":"Kocisova","year":"1988","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1218(91)90091-Y","article-title":"Increased frequency of sister chromatid exchange and chromatid breaks in lymphocytes after treatment of human volunteers with therapeutic doses of paracetamol","volume":"261","author":"Hongslo","year":"1991","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-1218(92)90065-8","article-title":"Normal chromosomal aberration frequencies in peripheral lymphocytes of healthy human volunteers exposed to a maximum daily dose of paracetamol in a double blind trial","volume":"279","author":"Kirkland","year":"1992","journal-title":"Mutation Res."},{"key":"10.1016\/j.mrgentox.2006.02.004_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrgentox.2004.11.015","article-title":"Assessment of DNA damage in peripheral blood of heavy smokers with the comet assay and the micronucleus test","volume":"581","author":"Hoffmann","year":"2005","journal-title":"Mutation Res."}],"container-title":["Mutation Research\/Genetic Toxicology and Environmental Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571806000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383571806000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T18:49:05Z","timestamp":1555699745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383571806000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1383571806000544"],"URL":"https:\/\/doi.org\/10.1016\/j.mrgentox.2006.02.004","relation":{},"ISSN":["1383-5718"],"issn-type":[{"value":"1383-5718","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}